Apyx Medical Corp 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001437749-25-033499
- Form type
- 10-Q
- CIK
- 0000719135
- Primary document
- https://www.sec.gov/Archives/edgar/data/719135/000143774925033499/apyx20250930_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Apyx Medical Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $33.7M | - | - |
| Cost Of Revenue | $12.6M | - | - |
| Gross Profit | $21.0M | - | - |
| Operating Income | $-6.5M | - | - |
| Net Income | $-9.9M | - | - |
| Eps Basic | -0.24 | - | - |
| Cash And Equivalents | $25.1M | - | - |
| Total Assets | $57.4M | - | - |
| Total Liabilities | $51.3M | - | - |
| Shareholders Equity | $5.8M | - | - |
| Operating Cash Flow | $-5.5M | - | - |
| Capital Expenditures | $839,000 | - | - |